| Jody M Barber, MD | |
|
620 W Edison Rd, Ste 110, Mishawaka, IN 46545-2784 | |
| (574) 258-1100 | |
| (574) 258-1101 |
| Full Name | Jody M Barber |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 24 Years |
| Location | 620 W Edison Rd, Mishawaka, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316919293 | NPI | - | NPPES |
| 200523810 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus Health Shreveport - Bossier | Shreveport, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Diagnostic Imaging Associates | 9133183213 | 16 |
News Archive
Imagine seeing a building on fire. You grab the phone and call the fire service. What happens next can be compared to the discovery made by researchers from Aarhus University.
Whether you're brainy, brawny or both, you may someday benefit from a drug found to rejuvenate aging brain and muscle tissue. Researchers at the University of California, Berkeley, have discovered that a small-molecule drug simultaneously perks up old stem cells in the brains and muscles of mice, a finding that could lead to drug interventions for humans that would make aging tissues throughout the body act young again.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
Parenteral nutrition is intravenous nutrition for patients who are unable to eat or be tube fed. It is used with more than 300,000 patients per year - a quarter of whom are children and newborns.
In 1955 medical literature first defined and described M.E., an illness that had probably been with us for hundreds of years. But with a wide range of symptoms, no diagnostic test and much misunderstanding about its cause, people with M.E. often had to struggle to manage the illness with little support from specialist services.
› Verified 7 days ago
| Entity Name | Radiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578557815 PECOS PAC ID: 5890695464 Enrollment ID: O20220716000080 |
News Archive
Imagine seeing a building on fire. You grab the phone and call the fire service. What happens next can be compared to the discovery made by researchers from Aarhus University.
Whether you're brainy, brawny or both, you may someday benefit from a drug found to rejuvenate aging brain and muscle tissue. Researchers at the University of California, Berkeley, have discovered that a small-molecule drug simultaneously perks up old stem cells in the brains and muscles of mice, a finding that could lead to drug interventions for humans that would make aging tissues throughout the body act young again.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
Parenteral nutrition is intravenous nutrition for patients who are unable to eat or be tube fed. It is used with more than 300,000 patients per year - a quarter of whom are children and newborns.
In 1955 medical literature first defined and described M.E., an illness that had probably been with us for hundreds of years. But with a wide range of symptoms, no diagnostic test and much misunderstanding about its cause, people with M.E. often had to struggle to manage the illness with little support from specialist services.
› Verified 7 days ago
| Entity Name | Diagnostic Imaging Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194807271 PECOS PAC ID: 9133183213 Enrollment ID: O20231005003184 |
News Archive
Imagine seeing a building on fire. You grab the phone and call the fire service. What happens next can be compared to the discovery made by researchers from Aarhus University.
Whether you're brainy, brawny or both, you may someday benefit from a drug found to rejuvenate aging brain and muscle tissue. Researchers at the University of California, Berkeley, have discovered that a small-molecule drug simultaneously perks up old stem cells in the brains and muscles of mice, a finding that could lead to drug interventions for humans that would make aging tissues throughout the body act young again.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
Parenteral nutrition is intravenous nutrition for patients who are unable to eat or be tube fed. It is used with more than 300,000 patients per year - a quarter of whom are children and newborns.
In 1955 medical literature first defined and described M.E., an illness that had probably been with us for hundreds of years. But with a wide range of symptoms, no diagnostic test and much misunderstanding about its cause, people with M.E. often had to struggle to manage the illness with little support from specialist services.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jody M Barber, MD 620 W Edison Rd, Ste 110, Mishawaka, IN 46545-2784 Ph: (574) 258-1100 | Jody M Barber, MD 620 W Edison Rd, Ste 110, Mishawaka, IN 46545-2784 Ph: (574) 258-1100 |
News Archive
Imagine seeing a building on fire. You grab the phone and call the fire service. What happens next can be compared to the discovery made by researchers from Aarhus University.
Whether you're brainy, brawny or both, you may someday benefit from a drug found to rejuvenate aging brain and muscle tissue. Researchers at the University of California, Berkeley, have discovered that a small-molecule drug simultaneously perks up old stem cells in the brains and muscles of mice, a finding that could lead to drug interventions for humans that would make aging tissues throughout the body act young again.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
Parenteral nutrition is intravenous nutrition for patients who are unable to eat or be tube fed. It is used with more than 300,000 patients per year - a quarter of whom are children and newborns.
In 1955 medical literature first defined and described M.E., an illness that had probably been with us for hundreds of years. But with a wide range of symptoms, no diagnostic test and much misunderstanding about its cause, people with M.E. often had to struggle to manage the illness with little support from specialist services.
› Verified 7 days ago
Samir B Patel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545 Phone: 574-258-1100 Fax: 574-258-1101 | |
James C Field, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545 Phone: 547-258-1100 Fax: 574-258-1101 | |
Mark J Ormson, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545 Phone: 574-258-1100 Fax: 574-258-1101 | |
John C Hill, DO Radiology Medicare: Not Enrolled in Medicare Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545 Phone: 574-258-1100 Fax: 574-258-1101 | |
Mary C Dynes, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545 Phone: 574-258-1100 Fax: 574-258-1101 | |
Francoise M Dion, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545 Phone: 574-258-1100 Fax: 574-258-1101 | |
Christine Marsch O'malley, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 620 W Edison Rd, Suite 110, Mishawaka, IN 46545 Phone: 574-258-1100 Fax: 574-258-1101 |